Skybiotech Healthcare (BOM:512036) EPS (Basic): ₹-4.42 (TTM As of Mar. 2026)


BOM:512036 Skybiotech Healthcare Ltd BOM:512036
21 GF Score
Price ₹199.95
! 5 Warning Signs
View Full Analysis

What is Skybiotech Healthcare EPS (Basic)?

Skybiotech Healthcare BOM:512036 21 EPS (Basic) is ₹-4.42 as of Mar. 2026. GuruFocus rates BOM:512036 with a GF Score™ of 21/100. The stock has 5 warning signs investors should review.

Skybiotech Healthcare's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹-1.59. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-4.42.

Skybiotech Healthcare's EPS (Diluted) for the three months ended in Mar. 2026 was ₹-1.59. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-4.42.

Skybiotech Healthcare's EPS without NRI for the three months ended in Mar. 2026 was ₹-1.59. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -4.42.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Skybiotech Healthcare  (BOM:512036) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Skybiotech Healthcare EPS (Basic) Related Terms

Skybiotech Healthcare EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Skybiotech Healthcare's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Skybiotech Healthcare EPS (Basic) Chart

Skybiotech Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.36 -2.32 3.67 -12.37 -5.83

Skybiotech Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.71 -0.25 -1.29 -1.29 -1.59
BOM:512036
21GF Score
Skybiotech Healthcare Ltd BOM:512036
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Skybiotech Healthcare EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Skybiotech Healthcare's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-11.168-0)/1.915
=-5.83

Skybiotech Healthcare's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-3.038-0)/1.915
=-1.59

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-4.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹-4.42 mean?
Skybiotech Healthcare (BOM:512036) has a EPS (Basic) of ₹-4.42 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Skybiotech Healthcare and its competitors.
Is Skybiotech Healthcare's EPS (Basic) too high?
Skybiotech Healthcare's current EPS (Basic) is ₹-4.42. Overall, Skybiotech Healthcare has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Skybiotech Healthcare's EPS (Basic) compare to HON and MMM?
Skybiotech Healthcare's EPS (Basic) of ₹-4.42 can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Conglomerates company?
A good EPS (Basic) depends on the Conglomerates industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Skybiotech Healthcare and its competitors. Skybiotech Healthcare's current EPS (Basic) is ₹-4.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skybiotech Healthcare stock overvalued right now?
Skybiotech Healthcare (BOM:512036) has a current EPS (Basic) of ₹-4.42. The current EPS (Basic) is ₹-4.42. Skybiotech Healthcare's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Skybiotech Healthcare (BOM:512036), the current EPS (Basic) is ₹-4.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Skybiotech Healthcare Business Description

Address Paithan Road, Gevrai Tanda, Gut No. 05, Chhatrapati Sambhaji Nagar, MH, IND, 431002
Skybiotech Healthcare Ltd, formerly Kapil Cotex Ltd is engaged in textiles and allied products, including dyeing, printing, spinning, weaving, and manufacturing fabrics from raw cotton. During the year under review, the company has not generated any revenue from its core business activities. Instead, it earned income from consultancy services for foreign clients and from investments in shares, generating capital gains and dividends. The company's current revenue mainly comes from these non-core activities rather than textile manufacturing.
21GF Score

Get the complete analysis for BOM:512036

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹199.95
Price